DSNKY Stock Price, Chart, Stats & News
Daiichi Sankyo Company, Limited (DSNKY) is a dividend-paying stock with a current dividend yield of 3.14% as of Sep 30, 2026. It pays $0.5593 per share over the trailing twelve months and distributes bi-annually. Its dividend has grown at a 14.46% 5-year compound annual rate.
Dividend safety
Dividend coverage is moderate for DSNKY — it pays out about 66% of earnings.
DSNKY chart
About
Daiichi Sankyo Company, Limited is a global pharmaceutical enterprise that encompasses the entire lifecycle of drug development, from pioneering research and development to manufacturing, importation, marketing, and worldwide distribution of its medicinal products. Its extensive and diverse portfolio features numerous key pharmaceutical offerings: Oncology: This includes trastuzumab deruxtecan (an anti-HER2 antibody-drug conjugate for cancer treatment), gefitinib for malignant tumors, bicalutamide for prostate cancer, and tamoxifen, an anti-breast cancer agent. Cardiovascular and Metabolic Health: The company provides teneligliptin and a combination of teneligliptin/canagliflozin for managing type 2 diabetes mellitus, along with colesevelam for both hypercholesterolemia and type 2 diabetes.
Related lists
Similar securities
Based on sector and market capitalization
